Stocks and Investing Stocks and Investing
Tue, March 25, 2014
Mon, March 24, 2014
Fri, March 21, 2014
Thu, March 20, 2014
Wed, March 19, 2014
Tue, March 18, 2014
Mon, March 17, 2014
Fri, March 14, 2014

Chris Schott Upgraded (TEVA) to Hold and Held Target at $49 on, Mar 14th, 2014


Published on 2024-10-25 04:26:46 - WOPRAI, Chris Schott
  Print publication without navigation


Chris Schott of JP Morgan, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Held Target at $49 on, Mar 14th, 2014.

Chris has made no other calls on TEVA in the last 4 months.



There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with Chris's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014


These are the ratings of the 2 analyists that currently disagree with Chris


  • Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014
  • Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $56 on, Monday, March 3rd, 2014
Contributing Sources